JPRN-UMIN000050630招募中Unknown
Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small-cell lung cancer and interstitial lung disease - Rechallenge chemotherapy with CBDCA+PTX/nab-PTX for patients with NSCLC and ILD
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Disagree to study registration
研究者
相似试验
已完成
2 期
Treatment outcome in head and neck cancer patients receiving carboplatin plus capecitabine based versus high dose cisplatin based chemoradiotherapy.CTRI/2020/11/029290Govt Kilpauk Medical College81
进行中（未招募）
1 期
Induction chemotherapy with Carboplatin and Navelbine Oral® followed by concomitant Navelbine Oral® and irradiation in local-regionally advanced non-small cell lung cancer. A randomized phase II study.EUCTR2008-008920-34-DKOdense University Hospital
已完成
2 期
Carboplatin chemotherapy and involved node radiotherapy in stage IIA/B seminoma.Seminoma stage IIa/bDRKS00005026SAKKSchweizerische Arbeitsgemeinschaft für Klinische Krebsforschung120
进行中（未招募）
1 期
Carboplatin chemotherapy and involved node radiotherapy in stageIIA/B seminoma.Patients with seminoma stage IIA/B, after orchidectomyEUCTR2011-005840-87-DESwiss Group for Clinical Cancer Research SAKK120
已完成
不适用
Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratomaCancerTesticular cancerISRCTN69711558Medical Research Council (MRC) (UK)450